Philips, Microsoft unveil augmented reality concept for image-guided minimally invasive therapies

Royal Philips has revealed the augmented reality concept for image-guided minimally invasive therapies it developed with Microsoft. The concept, which combines Philips’ Azurion platform with Microsoft’s HoloLens 2 computing platform, was unveiled at MWC Barcelona in Barcelona, Spain.

The project is designed to upgrade operating rooms by allowing physicians to perform minimally invasive therapies using “a 3D holographic augmented reality environment” they can easily control. A video detailing the technology is available here.

“The transition from open surgery to image-guided procedures has driven a seismic shift in improving patient outcomes and reducing costs—not least by dramatically reducing the length of time a patient stays in a hospital after their procedure,” Atul Gupta, MD, chief medical officer for image guided therapy at Philips and an interventional and diagnostic radiologist, said in a prepared statement. “On our Azurion platform we seamlessly integrate a range of data sources in a way that’s intuitive to understand and control. By collaborating with Microsoft and HoloLens 2 we can take it to the next level, immersing the physician in a tailored augmented reality environment.”

“Mixed reality is giving people new ways to interact with the digital and physical world, bringing the benefits of the digital revolution to entirely new experiences across the globe,” Alex Kipman, technical fellow in AI and mixed reality at Microsoft, said in the same statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.